These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8723474)

  • 1. Population pharmacokinetic study of teicoplanin in severely neutropenic patients.
    Lortholary O; Tod M; Rizzo N; Padoin C; Biard O; Casassus P; Guillevin L; Petitjean O
    Antimicrob Agents Chemother; 1996 May; 40(5):1242-7. PubMed ID: 8723474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of teicoplanin in children.
    Ramos-Martín V; Paulus S; Siner S; Scott E; Padmore K; Newland P; Drew RJ; Felton TW; Docobo-Pérez F; Pizer B; Pea F; Peak M; Turner MA; Beresford MW; Hope WW
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6920-7. PubMed ID: 25224001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of a modified bioassay for monitoring serum teicoplanin and vancomycin in febrile neutropenic patients.
    Kureishi A; Jewesson PJ; Bartlett KH; Cole CD; Chow AW
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1642-7. PubMed ID: 2149492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetic study of amikacin administered once or twice daily to febrile, severely neutropenic adults.
    Tod M; Lortholary O; Seytre D; Semaoun R; Uzzan B; Guillevin L; Casassus P; Petitjean O
    Antimicrob Agents Chemother; 1998 Apr; 42(4):849-56. PubMed ID: 9559795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of teicoplanin and attainment of pharmacokinetic/pharmacodynamic targets in adult patients with haematological malignancy.
    Byrne CJ; Roberts JA; McWhinney B; Ryder SA; Fennell JP; O'Byrne P; Deasy E; Egan S; Desmond R; Enright H; D'Arcy DM; McHugh J
    Clin Microbiol Infect; 2017 Sep; 23(9):674.e7-674.e13. PubMed ID: 28267636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population Pharmacokinetics of Teicoplanin in Preterm and Term Neonates: Is It Time for a New Dosing Regimen?
    Kontou A; Sarafidis K; Begou O; Gika HG; Tsiligiannis A; Ogungbenro K; Dokoumetzidis A; Agakidou E; Roilides E
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teicoplanin in patients with acute leukaemia and febrile neutropenia: a special population benefiting from higher dosages.
    Pea F; Viale P; Candoni A; Pavan F; Pagani L; Damiani D; Casini M; Furlanut M
    Clin Pharmacokinet; 2004; 43(6):405-15. PubMed ID: 15086277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patients.
    Chow AW; Jewesson PJ; Kureishi A; Phillips GL
    Eur J Haematol Suppl; 1993; 54():18-24. PubMed ID: 8365461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piperacillin/tazobactam/amikacin versus piperacillin/amikacin/teicoplanin in the empirical treatment of neutropenic patients.
    Micozzi A; Nucci M; Venditti M; Gentile G; Girmenia C; Meloni G; Martino P
    Eur J Clin Microbiol Infect Dis; 1993 Jan; 12(1):1-8. PubMed ID: 8385015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variations of teicoplanin concentrations in neutropenic patients.
    Gimenez F; Leblond V; Nguyen J; Serrand P; Binet JL; Grosset J; Thuillier A
    J Clin Pharm Ther; 1997 Jun; 22(3):187-90. PubMed ID: 9447473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of teicoplanin in patients undergoing chronic haemodialysis.
    Papaioannou MG; Marinaki S; Pappas M; Stamatiadis D; Giamarellos-Bourboulis EJ; Giamarellou H; Stathakis C
    Int J Antimicrob Agents; 2002 Mar; 19(3):233-6. PubMed ID: 11932147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teicoplanin dosing strategy for treatment of Staphylococcus aureus in Korean patients with neutropenic fever.
    Ahn BJ; Yim DS; Lee DG; Kwon JC; Kim SH; Choi SM
    Yonsei Med J; 2011 Jul; 52(4):616-23. PubMed ID: 21623604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population Pharmacokinetics of Teicoplanin and Its Dosing Recommendations for Neutropenic Patients With Augmented Renal Clearance for Hematological Malignancies.
    Sako KI; Nakamaru Y; Ikawa K; Maeda T; Goto S; Ishihara Y; Kato Y; Matsuda Y
    Ther Drug Monit; 2021 Aug; 43(4):519-526. PubMed ID: 34250964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics and dosing optimization of teicoplanin in children with malignant haematological disease.
    Zhao W; Zhang D; Storme T; Baruchel A; Declèves X; Jacqz-Aigrain E
    Br J Clin Pharmacol; 2015 Nov; 80(5):1197-207. PubMed ID: 26138279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teicoplanin in combination therapy for febrile episodes in neutropenic and non-neutropenic paediatric patients.
    Lemerle S; de La Rocque F; Lamy R; Fremaux A; Bernaudin F; Lobut JB; Reinert P
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():113-6. PubMed ID: 2965122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients.
    Hess U; Böhme C; Rey K; Senn HJ
    Support Care Cancer; 1998 Jul; 6(4):402-9. PubMed ID: 9695210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tools for the Individualized Therapy of Teicoplanin for Neonates and Children.
    Ramos-Martín V; Neely MN; Padmore K; Peak M; Beresford MW; Turner MA; Paulus S; López-Herce J; Hope WW
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered pharmacokinetics of piperacillin in febrile neutropenic patients with hematological malignancy.
    Sime FB; Roberts MS; Warner MS; Hahn U; Robertson TA; Yeend S; Phay A; Lehman S; Lipman J; Peake SL; Roberts JA
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3533-7. PubMed ID: 24687508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftriaxone alone or in Combination with Teicoplanin in the Management of Febrile Episodes in Neutropenic Children and Adolescents with Cancer on an Outpatient Base.
    Preis S; Jürgens H; Friedland C; Oudekotte-David AA; Thomas L; Göbel U
    Klin Padiatr; 1993; 205(4):295-9. PubMed ID: 8377450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piperacillin plus amikacin vs. piperacillin plus amikacin plus teicoplanin for empirical treatment of febrile episodes in neutropenic patients receiving quinolone prophylaxis.
    Martino P; Micozzi A; Gentile G; Raccah R; Girmenia C; Mandelli F
    Clin Infect Dis; 1992 Aug; 15(2):290-4. PubMed ID: 1387806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.